Immune Checkpoint Profiles in Luminal B Breast Cancer (Alliance). Anurag, Meenakshi , Zhu, Mayanne , Huang, Chen , Vasaikar, Suhas ... - - J. Natl. Cancer Inst. - 2020 Manuscript - Secondary-not-in-original - Primary - Correl Sci NOS - ACOSOG-Z1031
ACOSOG Z1031: A randomized phase II trial comparing exemestane, letrozole, and anastrozole in postmenopausal women with clinical stage II/III estrogen receptor-positive breast cancer Ellis, M. J. , Buzdar, A. U. , Unzeitig, G. W. , Esserman, L. J. ... - - J. Clin. Oncol. - 2010 Abstract - Primary - Primary - Breast - ACOSOG-Z1031
Whole-genome analysis informs breast cancer response to aromatase inhibition Ellis, M. J. , Ding, L. , Shen, D. , Luo, J. Q. , Suman, V. J. ... - - Nature - 2012 Manuscript - Secondary-not-in-original - Comprehensive - PPP - ACOSOG-Z1031
Z1031B neoadjuvant aromatase inhibitor trial: A Phase 2 study of triage to chemotherapy based on 2 to 4 week Ki67 level >10% Ellis, M. J. , Suman, V , McCall, L. , Luo, R. , Hoog, J. , Brink, A. ... - AACR - Cancer Res. - 2012 Abstract - Primary - Primary - Breast - ACOSOG-Z1031B
Tumor Ki67 Proliferation Index within 4 Weeks of Initiating Neoadjuvant Endocrine Therapy for Early Identification of Non-Responders Ellis, M. , Luo, J. , Tao, Y. , Hoog, J. , Snider, J. , DeSchryver, K. ... - - Cancer Research - 2009 Abstract - Secondary - Primary - Correl Sci NOS - ACOSOG-Z1031
Ki67 Proliferation Index as a Tool for Chemotherapy Decisions During and After Neoadjuvant Aromatase Inhibitor Treatment of Breast Cancer: Results From the American College of Surgeons Oncology Group Z1031 Trial (Alliance) Ellis, Matthew J. , Suman, Vera J. , Hoog, Jeremy ... - - J. Clin. Oncol - 2017 Manuscript - Secondary - Primary - Breast - ACOSOG-Z1031B
Randomized Phase II Neoadjuvant Comparison Between Letrozole, Anastrozole, and Exemestane for Postmenopausal Women With Estrogen Receptor–Rich Stage 2 to 3 Breast Cancer: Clinical and Biomarker Outcomes and Predictive Value of the Baseline PAM50-Based Intrinsic Subtype—ACOSOG Z1031 Ellis, Matthew J. , Suman, Vera J. , Hoog, Jeremy , Lin, Li ... - - J. Clin. Oncol. - 2011 Manuscript - Primary - Primary - Breast - ACOSOG-Z1031
Phosphatidyl-inositol-3-kinase alpha catalytic subunit mutation and response to neoadjuvant endocrine therapy for estrogen receptor positive breast cancer Ellis, Matthew J , Lin, Li , Crowder, Robert , Tao, Yu , Hoog, Jeremy ... - - Breast Cancer Res Treat - 2010 Manuscript - Secondary-not-in-original - Primary - Correl Sci NOS - ACOSOG-Z1031
Accrual of Older Patients With Breast Cancer to Alliance Systemic Therapy Trials Over Time: Protocol A151527 Freedman, Rachel A. , Foster, Jared C. , Seisler, Drew K. ... - - J. Clin. Oncol - 2017 Manuscript - Primary - Primary - Older Adult - A151527 , ACOSOG-Z1031 , ACOSOG-Z1041 , C8541 , C9344 , C9741 , CALGB-40101 , CALGB-40302 , CALGB-40502 , CALGB-40503 , CALGB-40601 , CALGB-40603 , CALGB-49907 , CALGB-9342 , CALGB-9840 , N89-30-52 , N9831
Accrual of Older Breast Cancer Patients to Alliance Systemic Therapy Protocols over Time: Alliance A151527 Freedman, Rachel A , Seisler, Drew K. , Foster, Jared C. ... - ASCO - J. Clin. Oncol. - 2016 Abstract - Primary - Primary - Older Adult - A151527 , ACOSOG-Z1031 , ACOSOG-Z1041 , C8541 , C9344 , C9741 , CALGB-40101 , CALGB-40302 , CALGB-40502 , CALGB-40503 , CALGB-40601 , CALGB-40603 , CALGB-49907 , CALGB-9342 , CALGB-9840 , N89-30-52 , N9831
Loss of MutL Disrupts CHK2-Dependent Cell-Cycle Control through CDK4/6 to Promote Intrinsic Endocrine Therapy Resistance in Primary Breast Cancer. Haricharan, Svasti , Punturi, Nindo , Singh, Purba ... - - Cancer Discov - 2017 Manuscript - Secondary-not-in-original - Primary - Correl Sci NOS - ACOSOG-Z1031
Functional Annotation of ESR1 Gene Fusions in Estrogen Receptor-Positive Breast Cancer Lei, Jonathan T. , Shao, Jieya , Zhang, Jin , Iglesia, Michael ... - - Cell Rep - 2018 Manuscript - Secondary - Primary - Correl Sci NOS - ACOSOG-Z1031
An mRNA Gene Expression–Based Signature to Identify FGFR1-Amplified Estrogen Receptor–Positive Breast Tumors Luo, Jingqin , Liu, Shuzhen , Leung, Samuel , Gru, Alejandro A. ... - - J Mol Diagn - 2017 Manuscript - Secondary - Primary - Correl Sci NOS - ACOSOG-Z1031
Aromatase inhibition remodels the clonal architecture of estrogen-receptor-positive breast cancers Miller, Christopher A. , Gindin, Yevgeniy , Lu, Charles ... - - Nat Commun - 2016 Manuscript - Secondary-not-in-original - Primary - Correl Sci NOS - ACOSOG-Z1031
ACOSOG Z1031: A randomized phase II trial comparing exemestane, letrozole and anastrozole in postmenopausal women with clinical stage II/III estrogen receptor positive breast cancer Olson, J. A. Jr , Babiera, G. V. , Unzeitig, G. , Marcom, P. K. ... - ASCO Breast - Breast Cancer Symposium - 2010 Abstract - Primary - Primary - Breast - ACOSOG-Z1031
Validation of the Preoperative Endocrine Prognostic Index in the ACOSOG (Alliance) Z1031 Neoadjuvant Aromatase Inhibitor Trial Sanati, Souzan , Suman, Vera J. , Goncalves, R. , DeSchryver, K. ... - SABCS - Cancer Res. - 2015 Abstract - Secondary - Primary - Breast - ACOSOG-Z1031B
Age, Race, BMI and Pathologic Complete Response Following Neoadjuvant Chemotherapy: An Analysis of Four Alliance Clinical Trials Warner, Erica T. , Ballman, Karla V. , Strand, Carrie ... - ASCO Breast - J. Clin. Oncol. - 2015 Abstract - Primary - Primary - Disparities - A151426 , ACOSOG-Z1031 , ACOSOG-Z1041 , CALGB-40601 , CALGB-40603
